Drug Survival of Apremilast for Psoriatic Arthritis in a Real-World Setting: A Single-Center Experience

被引：1

作者：

Foti, Rosario ^{[1
]}

Visalli, Elisa ^{[1
]}

Amato, Giorgio ^{[1
]}

Dal Bosco, Ylenia ^{[1
]}

Foti, Roberta ^{[1
]}

Baccano, Giacomo ^{[1
,2
]}

机构：

[1] AOU Policlin San Marco, Div Rheumatol, I-95123 Catania, Italy

[2] Azienda Osped Univ Policlin Vittorio Emanuele Cata, Rheumatol, Via Santa Sofia 78, I-95123 Catania, Italy

来源：

JOURNAL OF RHEUMATOLOGY | 2023年 / 50卷 / 03期

关键词：

ORAL PHOSPHODIESTERASE-4 INHIBITOR; SEVERE PLAQUE PSORIASIS; CONTROLLED-TRIAL; PHASE-III; EFFICACY; MODERATE; SAFETY;

D O I：

10.3899/jrheum.220333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：458 / +

页数：2

共 7 条

[1] Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3) [J].

Edwards, Christopher J. ;

Blanco, Francisco J. ;

Crowley, Jeffrey ;

Birbara, Charles A. ;

Jaworski, Janusz ;

Aelion, Jacob ;

Stevens, Randall M. ;

Vessey, Adele ;

Zhan, Xiaojiang ;

Bird, Paul .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) :1065-1073

[2]

Favalli EG, 2020, CLIN EXP RHEUMATOL, V38, P19

[3] Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor [J].

Kavanaugh, Arthur ;

Mease, Philip J. ;

Gomez-Reino, Juan J. ;

Adebajo, Adewale O. ;

Wollenhaupt, Juergen ;

Gladman, Dafna D. ;

Lespessailles, Eric ;

Hall, Stephen ;

Hochfeld, Marla ;

Hu, ChiaChi ;

Hough, Douglas ;

Stevens, Randall M. ;

Schett, Georg .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :1020-1026

[4] Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) [J].

Papp, Kim ;

Reich, Kristian ;

Leonardi, Craig L. ;

Kircik, Leon ;

Chimenti, Sergio ;

Langley, Richard G. B. ;

Hu, ChiaChi ;

Stevens, Randall M. ;

Day, Robert M. ;

Gordon, Kenneth B. ;

Korman, Neil J. ;

Griffiths, Christopher E. M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :37-49

[5] Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) [J].

Paul, C. ;

Cather, J. ;

Gooderham, M. ;

Poulin, Y. ;

Mrowietz, U. ;

Ferrandiz, C. ;

Crowley, J. ;

Hu, C. ;

Stevens, R. M. ;

Shah, K. ;

Day, R. M. ;

Girolomoni, G. ;

Gottlieb, A. B. .

BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) :1387-1399

[6] Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study [J].

Schett, Georg ;

Wollenhaupt, Jurgen ;

Papp, Kim ;

Joos, Rik ;

Rodrigues, Jude F. ;

Vessey, Adele R. ;

Hu, ChiaChi ;

Stevens, Randall ;

de Vlam, Kurt L. .

ARTHRITIS AND RHEUMATISM, 2012, 64 (10) :3156-3167

[7] Classification criteria for psoriatic arthritis - Development of new criteria from a large international study [J].

Taylor, William ;

Gladman, Dafna ;

Helliwell, Philip ;

Marchesoni, Antonio ;

Mease, Philip ;

Mielants, Herman .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2665-2673

← 1 →